Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2009 1
2010 1
2011 1
2012 1
2017 1
2019 1
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Long-term fracture risk in rheumatoid arthritis: impact of early sustained DAS28-remission and restored function, progressive erosive disease, body mass index, autoantibody positivity and glucocorticoids. A cohort study over 10 years.
Ajeganova S, Andersson M, Forslind K, Gjertsson I, Nyhäll-Wåhlin BM, Svensson B, Hafström I. Ajeganova S, et al. Among authors: nyhall wahlin bm. BMC Rheumatol. 2023 Aug 7;7(1):23. doi: 10.1186/s41927-023-00347-6. BMC Rheumatol. 2023. PMID: 37550762 Free PMC article.
Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006-2011.
Ziegelasch M, Boman A, Martinsson K, Thyberg I, Jacobs C, Nyhäll-Wåhlin BM, Svärd A, Berglin E, Rantapää-Dahlqvist S, Skogh T, Kastbom A. Ziegelasch M, et al. Among authors: nyhall wahlin bm. Scand J Rheumatol. 2020 Nov;49(6):434-442. doi: 10.1080/03009742.2020.1771761. Epub 2020 Aug 28. Scand J Rheumatol. 2020. PMID: 32856532 Free article.
Severe Extraarticular Manifestations in a Community-based Cohort of Patients with Rheumatoid Arthritis: Risk Factors and Incidence in Relation to Treatment with Tumor Necrosis Factor Inhibitors.
Theander L, Nyhäll-Wåhlin BM, Nilsson JÅ, Willim M, Jacobsson LTH, Petersson IF, Turesson C. Theander L, et al. Among authors: nyhall wahlin bm. J Rheumatol. 2017 Jul;44(7):981-987. doi: 10.3899/jrheum.161103. Epub 2017 May 1. J Rheumatol. 2017. PMID: 28461642